Patents and IP platform
LIDDS technology platform and product Liproca® Depot in patent applications worldwide, including five patent families. The patent work is ongoing and patent licenses are granted continuously country after country. All patent applications (5 patent families) is in the so-called national phase and is approaching the country of approval for the country. The patents for the active pharmaceutical substance flutamide and 2-hydroxy-flutamide has expired long ago and can therefore be used freely by LIDDS to compose new medical preparations based on LIDDS unique intellectual property.